Novavax raising $82M for vaccine R&D; Achaogen, FDA agree on SPA;

@FierceBiotech: The 2013 Fierce 15 biotech execs take a bow. Editor's corner | FierceBiotech's 2013 Fierce 15 | Follow @FierceBiotech

@JohnCFierce: Merck KGaA doubles down on Oncothyreon's failed cancer vaccine. Report | Follow @JohnCFierce

@DamianFierce: Apparently no one wanted to spend ~$3B on Clovis Oncology. Perhaps Big Pharma wants its biotechs to generate revenue. Story | Follow @DamianFierce

@EmilyMFierce: Stem cell reprogramming made easier by removing one protein. Popular yesterday from FierceBiotech Research | Follow @EmilyMFierce

> Rockville, MD-based Novavax ($NVAX) plans to raise $82 million from the sale of common stock. The new financing is intended to finance work on its pipeline of vaccines. Release

> South San Francisco-based Achaogen and the FDA have reached agreement on an SPA for a Phase III clinical trial of plazomicin in patients with serious multi-drug resistant gram-negative bacterial infections. Release

> San Diego-based La Jolla Pharmaceutical says it has raised $10 million in a new financing effort. Release

Medical Device News

@FierceMedDev: Biocept Laboratories becomes latest Dx outfit to explore IPO. ICYMI yesterday | Follow @FierceMedDev

@MarkHFierce: Medtronic won expanded indications for one of its key vascular stents. Release | Article | Follow @MarkHFierce

> Stryker inks $1.7B deal for Mako. News

> Tool to predict bad implant reactions shows potential. Item

> EnteroMedics slides after FDA squints at obesity device. Article

Pharma News

@FiercePharma: Lundbeck's refusal to sell pentobarbital to prisons hits Ohio's execution plans. More from Reuters | Follow @FiercePharma

@EricPFierce: FDA warning letter for Strides Arcolab Agila Speciaities plant arrives. Mylan not too concerned. Story from FiercePharmaManufacturing | Follow @EricPFierce

> Cost gatekeepers give final 'no' to Pfizer's targeted cancer drug Xalkori. Report

> Eli Lilly's diabetes strategy doesn't include big staff-up in sales. Article

Drug Delivery News

@MichaelGFierce: Laser-sensitive surface enables IV-drug identification for safer delivery. Story | Follow @MichaelGFierce

> Study: Artificial pancreas with inhaled insulin improves glucose control. More

> Alnylam heralds positive results for RNAi amyloidosis drug. Article

> Surefire collects $16.4M to expand cancer-drug catheter biz. Item

> Bind collects $70.5M IPO to support Accurin tech. Story

Diagnostics News

> Cognoptix Alzheimer's eye test generates robust trial results. Article

> Alzheimer's diagnosis may gain from PET imaging of tau proteins. Report

> Case Western, GSK find promise with MS diagnostic 'probe.' Story

> In vitro Dx to remain at top of med tech heap. More

> Cigna: Genetic counseling mandates will come for other Dx tests. Article

And Finally… A nail fungus drug has been proven effective at wiping out HIV in cell cultures. Story